Flare levels after intravitreal injection of brolucizumab for diabetic macular edema
Sign Up to like & getrecommendations! Published in 2024 at "Graefe's Archive for Clinical and Experimental Ophthalmology"
DOI: 10.1007/s00417-024-06374-4
Abstract: This study aimed to evaluate anterior flare intensity (AFI) after intravitreal injection of brolucizumab (IVBr) in patients with diabetic macular edema (DME), and to identify the factors associated with the change of AFI after IVBr.… read more here.
Keywords: flare; intravitreal injection; injection; afi ... See more keywords
Novel approach towards Al-rich AFI for catalytic application
Sign Up to like & getrecommendations! Published in 2019 at "Applied Catalysis A: General"
DOI: 10.1016/j.apcata.2019.03.015
Abstract: Abstract A new germanosilicate structural analogue of AFI zeolite (Ge-AFI) was hydrothermally synthesized. One- and two-step alumination of the Ge-AFI zeolites were used to modify their structure and acidic properties traced using XRD, N2 adsorption,… read more here.
Keywords: approach towards; novel approach; afi catalytic; towards rich ... See more keywords
Abstract 4364366: Myosin modulator Aficamten inhibits force in cardiac muscle by altering myosin’s biochemical activity without changing thick filament structure
Sign Up to like & getrecommendations! Published in 2025 at "Circulation"
DOI: 10.1161/circ.152.suppl_3.4364366
Abstract: Introduction: Inhibiting contractility by targeting cardiac myosin is an effective treatment for patients with hypertrophic cardiomyopathy (HCM). Aficamten (Afi), a second in class myosin inhibitor, improves hemodynamics and symptoms in HCM patients. While it is… read more here.
Keywords: myosin; thick filament; structure; force ... See more keywords